134 related articles for article (PubMed ID: 18983858)
1. The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway.
Jiang WG; Ablin RJ; Kynaston HG; Mason MD
Microvasc Res; 2009 Mar; 77(2):150-7. PubMed ID: 18983858
[TBL] [Abstract][Full Text] [Related]
2. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
Davies G; Ablin RJ; Mason MD; Jiang WG
J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
[TBL] [Abstract][Full Text] [Related]
3. Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.
Ablin RJ; Kynaston HG; Mason MD; Jiang WG
J Transl Med; 2011 Apr; 9():49. PubMed ID: 21524313
[TBL] [Abstract][Full Text] [Related]
4. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
[TBL] [Abstract][Full Text] [Related]
5. Prostate transglutaminase (TGase-4, TGaseP) enhances the adhesion of prostate cancer cells to extracellular matrix, the potential role of TGase-core domain.
Jiang WG; Ye L; Sanders AJ; Ruge F; Kynaston HG; Ablin RJ; Mason MD
J Transl Med; 2013 Oct; 11():269. PubMed ID: 24161123
[TBL] [Abstract][Full Text] [Related]
6. Distribution and expression of CD44 isoforms and Ezrin during prostate cancer-endothelium interaction.
Harrison GM; Davies G; Martin TA; Jiang WG; Mason MD
Int J Oncol; 2002 Nov; 21(5):935-40. PubMed ID: 12370738
[TBL] [Abstract][Full Text] [Related]
7. Prostate Transglutaminase (TGase-4) Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells.
Ablin RJ; Owen S; Jiang WG
Anticancer Res; 2017 Feb; 37(2):481-487. PubMed ID: 28179293
[TBL] [Abstract][Full Text] [Related]
8. The prostate transglutaminase, TGase-4, coordinates with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cells.
Jiang WG; Ye L; Ablin RJ; Kynaston HG; Mason MD
Int J Oncol; 2010 Aug; 37(2):413-8. PubMed ID: 20596668
[TBL] [Abstract][Full Text] [Related]
9. Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells.
Park KS; Han BG; Lee KH; Kim DS; Kim JM; Jeon H; Kim HS; Suh SW; Lee EH; Kim SY; Lee BI
Cancer Lett; 2009 Feb; 274(2):201-7. PubMed ID: 18851895
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
11. Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
Kuo PT; Lin TP; Liu LC; Huang CH; Lin JK; Kao JY; Way TD
J Agric Food Chem; 2009 Apr; 57(8):3331-9. PubMed ID: 19320436
[TBL] [Abstract][Full Text] [Related]
12. Antisense inhibition of transglutaminase 2 affects development of mouse embryo submandibular gland in organ culture.
Lee SK; Kim YS; Lee SS; Lee YJ; Song IS; Park SC; Chi JG; Chung SI
Arch Oral Biol; 2005 Sep; 50(9):789-98. PubMed ID: 15970210
[TBL] [Abstract][Full Text] [Related]
13. [Interferon-gamma decreases the adhesiveness and invasiveness of prostate cancer cells].
Gao L; Yang DJ; Lin XG; Xu WH; Wang XM
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):513-6. PubMed ID: 18649748
[TBL] [Abstract][Full Text] [Related]
14. The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
Zoubeidi A; Rocha J; Zouanat FZ; Hamel L; Scarlata E; Aprikian AG; Chevalier S
Mol Cancer Res; 2009 Jan; 7(1):142-55. PubMed ID: 19147545
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer cell adhesion to quiescent endothelial cells is not mediated by beta-1 integrin subunit.
Cooper CR; McLean L; Mucci NR; Poncza P; Pienta KJ
Anticancer Res; 2000; 20(6B):4159-62. PubMed ID: 11205242
[TBL] [Abstract][Full Text] [Related]
16. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
Gandellini P; Folini M; Longoni N; Pennati M; Binda M; Colecchia M; Salvioni R; Supino R; Moretti R; Limonta P; Valdagni R; Daidone MG; Zaffaroni N
Cancer Res; 2009 Mar; 69(6):2287-95. PubMed ID: 19244118
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase inhibitors alter adhesivity of prostatic cancer cells to extracellular matrix components.
Skogseth H; Holt RU; Larsson E; Halgunset J
APMIS; 2006 Mar; 114(3):225-33. PubMed ID: 16643189
[TBL] [Abstract][Full Text] [Related]
18. Immunological characterization and activity of transglutaminases in human normal and malignant prostate and in prostate cancer cell lines.
Friedrichs B; Riedmiller H; Goebel HW; Rausch U; Aumüller G
Urol Res; 1995; 23(5):301-310. PubMed ID: 8839386
[TBL] [Abstract][Full Text] [Related]
19. A new regulatory mechanism of NF-kappaB activation by I-kappaBbeta in cancer cells.
Kim JM; Voll RE; Ko C; Kim DS; Park KS; Kim SY
J Mol Biol; 2008 Dec; 384(4):756-65. PubMed ID: 18950638
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of transglutaminase II leads to impaired motility of cancer cells by inactivation of the protein kinase, Akt, and decrease of reactive oxygen species.
Bae J; Lee YS; Jeoung D
Biotechnol Lett; 2006 Aug; 28(15):1151-8. PubMed ID: 16807769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
